DETAILS, FICTION AND MCC950 CHEMICAL STRUCTURE

] These attributes make SMS beneficial in regions like the coronary arteries where NIH is considerably less aggressive and permits clinicians to prioritize affected individual safety.[] Regardless of the short‐term Added benefits PTX and SMS have on NIH, a limitation of such anti‐proliferative agents is delayed re‐endothelialization.[] On the